Genetic risk test for periodontal disease highlighted during ADA annual meeting
Interleukin’s Chief Executive Officer Kenneth S. Kornman, DDS, PhD presented on the topic of genetic testing as part of risk stratification for preventive dental care at the 2014 ADA annual meeting.